The long-term clinical impact of COPD exacerbations : a 3-year observational study (SHERLOCK)
| dc.contributor.author | Haughney, John | |
| dc.contributor.author | Lee, Amanda J. | |
| dc.contributor.author | Nath, Mintu | |
| dc.contributor.author | Müllerová, Hana | |
| dc.contributor.author | Holmgren, Ulf | |
| dc.contributor.author | Nigris, Enrico de | |
| dc.contributor.author | Ding, Bo | |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Statistics | en |
| dc.date.accessioned | 2022-03-07T20:09:01Z | |
| dc.date.available | 2022-03-07T20:09:01Z | |
| dc.date.issued | 2022 | |
| dc.description | Acknowledgements Medical writing support, under the direction of the authors, was provided by Sara Cameron, M. Phil., of CMC Connect, McCann Health Medical Communications, funded by AstraZeneca in accordance with Good Publication Practice (GPP3) guidelines. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by AstraZeneca. Employees of AstraZeneca were involved in the design of the study, interpretation of the data (but not the data collection), in the writing of the report, and in the decision to submit the article for publication. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 506383 | |
| dc.identifier | 214278584 | |
| dc.identifier | 58203226-4d6e-4ebd-a064-6344127a112e | |
| dc.identifier | 85124587676 | |
| dc.identifier | 35156488 | |
| dc.identifier.citation | Haughney, J, Lee, A J, Nath, M, Müllerová, H, Holmgren, U, Nigris, E D & Ding, B 2022, 'The long-term clinical impact of COPD exacerbations : a 3-year observational study (SHERLOCK)', Therapeutic advances in respiratory disease, vol. 16, 17534666211070139. https://doi.org/10.1177/17534666211070139 | en |
| dc.identifier.doi | 10.1177/17534666211070139 | |
| dc.identifier.issn | 1753-4658 | |
| dc.identifier.other | ORCID: /0000-0002-4865-9061/work/159078030 | |
| dc.identifier.other | ORCID: /0000-0002-0753-0464/work/161797526 | |
| dc.identifier.uri | https://hdl.handle.net/2164/18169 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85124587676&partnerID=8YFLogxK | en |
| dc.identifier.vol | 16 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Therapeutic advances in respiratory disease | en |
| dc.subject | chronic obstructive pulmonary disease | en |
| dc.subject | exacerbations | en |
| dc.subject | risk | en |
| dc.subject | R Medicine | en |
| dc.subject | Pulmonary and Respiratory Medicine | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R | en |
| dc.title | The long-term clinical impact of COPD exacerbations : a 3-year observational study (SHERLOCK) | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Haughney_et_al_Long_term_Clinical_Therapeutic_Advances_in_Respiratory_Disease_vor.pdf
- Size:
- 494.51 KB
- Format:
- Adobe Portable Document Format
